Clinical Trial Update: REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing reduced-dose versus full-dose direct oral anticoagulant after unprovoked venous thromboembolism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Snippet

Sponsor: University Hospital, Brest | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED